过去几天对生物科技公司Amylyx Pharmaceuticals ...

European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...

South Africa's biggest companies are exploring widening a partnership with the government to help resolve a water crisis that ...

Halloween is two weeks away, which means pretty soon, many of us will be shopping for candy to give out to trick-or-treaters.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

H.C. Wainwright维持对Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX)的买入评级，目标价格保持在$8.00。 该公司的认可是在Amylyx最近宣布积极的试验结果之后。周四披露的HELIOS试验数据显示，主要终点C肽水平和次要生物标志物HbA1c水平均持续改善。这些结果表明，Wolfram综合征患者的疾病进展有所减缓。 延长至36周和48周的试验数据 ...

HELIOS is a Phase II trial evaluating the safety, tolerability and effects of AMX0035 in adults with Wolfram syndrome.